Subscribe to our weekly newsletter to get the latest updates in the Converting Industry!
First Name *
Last Name *
Your Name (required)
Your Email (required)
The compay has already raked in an estimated $1 billion in revenue after just nine months of selling Ocrevus on the U.S. market.
Read more: Roche gains EU approval for key MS drug